COGNICURRENT

Feb 2 • 21:33 UTC • 🇧🇷 Brazil • Folha (PT)

Anvisa approves indication of Ozempic and Wegovy to reduce the risk of heart attack and stroke

Anvisa has approved the use of semaglutide for adults with established cardiovascular disease or obesity to reduce the risk of heart attack and stroke.

#anvisa #ozempic #wegovy #semaglutide #obesity

Read Original Back to Feed

📡 Similar Coverage

🇧🇷 Brazil Feb 15 • 07:00 UTC

Anvisa says it will comment in the coming weeks on the registration of two competitors to Ozempic

Folha (PT)

🇧🇷 Brazil Feb 2 • 18:12 UTC

Anvisa approves the use of semaglutide for reducing cardiovascular risk

G1 (PT)

🇲🇽 Mexico Feb 9 • 22:36 UTC

Warning about self-medication with Ozempic and Wegovy; drugs are used as a treatment for weight loss

Milenio (ES)

🇧🇷 Brazil Feb 18 • 11:15 UTC

Anvisa is set to decide next week on national versions of Ozempic

G1 (PT)

🇬🇧 UK Feb 7 • 13:02 UTC

Warning about Ozempic and Wegovy as a rare side effect could cause sudden blindness

Mirror

🇫🇮 Finland Feb 2 • 19:08 UTC

Another new warning about hit medications

Iltalehti